New transparency policy ideas will be discussed on Monday, November 8th at 11 AM ET at the Advisory Committee on Transparency’s fourth event of 2021. Presenters include transparency experts from across the political spectrum, including OpenSecrets' Investigative Researcher, Anna Massoglia. RSVP here.
OpenSecrets is Looking For Interns!
OpenSecrets' reporting internship program is looking for writers with political knowledge and an interest in money-in-politics for the spring semester. Intern responsibilities include writing breaking news items and longer in-depth pieces for OpenSecrets News.
The deadline is fast approaching, apply by Nov. 15. More.
OpenSecrets in the News
See our media citations from outlets around the nation this week:
A bitter pill: Biden suffers familiar defeat on prescription drug prices (The Washington Post) All of them pledged to tackle high drug costs, and all of them failed at the hands of the deep-pocketed industry, which has spent more than $1 billion on lobbying and advertising over two decades to torpedo initiatives that could rein in its profits, according to data tracked by OpenSecrets, a government transparency group.
The Massive Progressive Dark-Money Group You’ve Never Heard Of (The Atlantic) The Sixteen Thirty Fund—the indisputable heavyweight of Democratic dark money—was the second-largest super-PAC donor in 2020, according to the investigative organization OpenSecrets, giving roughly $61 million of effectively untraceable money to progressive causes.
"They have really endless resources": Big Pharma spending $263M to keep drug prices high (CBS News) The pharmaceutical industry has spent nearly $263 million on lobbying so far this year, employing three lobbyists for every member of Congress, according to OpenSecrets, which tracks money in politics. Millions of those dollars are in the form of campaign donations. "They have really endless resources to throw at shaping the outcomes of legislation," said Sheila Krumholz, the executive director of OpenSecrets.
